PortfoliosLab logo
BMY vs. UNH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BMY and UNH is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

BMY vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bristol-Myers Squibb Company (BMY) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

BMY:

0.36

UNH:

-1.00

Sortino Ratio

BMY:

0.70

UNH:

-1.18

Omega Ratio

BMY:

1.08

UNH:

0.79

Calmar Ratio

BMY:

0.20

UNH:

-0.76

Martin Ratio

BMY:

1.13

UNH:

-2.74

Ulcer Index

BMY:

8.62%

UNH:

15.44%

Daily Std Dev

BMY:

31.53%

UNH:

43.33%

Max Drawdown

BMY:

-70.62%

UNH:

-82.68%

Current Drawdown

BMY:

-35.93%

UNH:

-52.93%

Fundamentals

Market Cap

BMY:

$95.14B

UNH:

$279.41B

EPS

BMY:

$2.73

UNH:

$21.29

PE Ratio

BMY:

17.12

UNH:

12.89

PEG Ratio

BMY:

2.26

UNH:

0.59

PS Ratio

BMY:

2.00

UNH:

0.68

PB Ratio

BMY:

5.36

UNH:

2.62

Total Revenue (TTM)

BMY:

$47.64B

UNH:

$407.42B

Gross Profit (TTM)

BMY:

$31.43B

UNH:

$87.53B

EBITDA (TTM)

BMY:

$16.18B

UNH:

$31.08B

Returns By Period

In the year-to-date period, BMY achieves a -15.53% return, which is significantly higher than UNH's -42.05% return. Over the past 10 years, BMY has underperformed UNH with an annualized return of -0.58%, while UNH has yielded a comparatively higher 10.96% annualized return.


BMY

YTD

-15.53%

1M

-5.29%

6M

-15.02%

1Y

11.19%

5Y*

-2.62%

10Y*

-0.58%

UNH

YTD

-42.05%

1M

-50.10%

6M

-50.31%

1Y

-43.10%

5Y*

1.55%

10Y*

10.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BMY vs. UNH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMY
The Risk-Adjusted Performance Rank of BMY is 6161
Overall Rank
The Sharpe Ratio Rank of BMY is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of BMY is 5757
Sortino Ratio Rank
The Omega Ratio Rank of BMY is 5454
Omega Ratio Rank
The Calmar Ratio Rank of BMY is 6161
Calmar Ratio Rank
The Martin Ratio Rank of BMY is 6565
Martin Ratio Rank

UNH
The Risk-Adjusted Performance Rank of UNH is 55
Overall Rank
The Sharpe Ratio Rank of UNH is 44
Sharpe Ratio Rank
The Sortino Ratio Rank of UNH is 99
Sortino Ratio Rank
The Omega Ratio Rank of UNH is 55
Omega Ratio Rank
The Calmar Ratio Rank of UNH is 77
Calmar Ratio Rank
The Martin Ratio Rank of UNH is 00
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BMY vs. UNH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current BMY Sharpe Ratio is 0.36, which is higher than the UNH Sharpe Ratio of -1.00. The chart below compares the historical Sharpe Ratios of BMY and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

BMY vs. UNH - Dividend Comparison

BMY's dividend yield for the trailing twelve months is around 5.22%, more than UNH's 2.88% yield.


TTM20242023202220212020201920182017201620152014
BMY
Bristol-Myers Squibb Company
5.22%4.24%4.44%3.00%2.36%3.69%2.55%3.08%2.55%1.95%2.17%2.46%
UNH
UnitedHealth Group Incorporated
2.88%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%1.39%

Drawdowns

BMY vs. UNH - Drawdown Comparison

The maximum BMY drawdown since its inception was -70.62%, smaller than the maximum UNH drawdown of -82.68%. Use the drawdown chart below to compare losses from any high point for BMY and UNH. For additional features, visit the drawdowns tool.


Loading data...

Volatility

BMY vs. UNH - Volatility Comparison

The current volatility for Bristol-Myers Squibb Company (BMY) is 11.57%, while UnitedHealth Group Incorporated (UNH) has a volatility of 33.07%. This indicates that BMY experiences smaller price fluctuations and is considered to be less risky than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

BMY vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B20212022202320242025
11.20B
109.58B
(BMY) Total Revenue
(UNH) Total Revenue
Values in USD except per share items

BMY vs. UNH - Profitability Comparison

The chart below illustrates the profitability comparison between Bristol-Myers Squibb Company and UnitedHealth Group Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
72.9%
21.7%
(BMY) Gross Margin
(UNH) Gross Margin
BMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a gross profit of 8.17B and revenue of 11.20B. Therefore, the gross margin over that period was 72.9%.

UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a gross profit of 23.77B and revenue of 109.58B. Therefore, the gross margin over that period was 21.7%.

BMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported an operating income of 3.52B and revenue of 11.20B, resulting in an operating margin of 31.4%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported an operating income of 9.12B and revenue of 109.58B, resulting in an operating margin of 8.3%.

BMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bristol-Myers Squibb Company reported a net income of 2.46B and revenue of 11.20B, resulting in a net margin of 21.9%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, UnitedHealth Group Incorporated reported a net income of 6.29B and revenue of 109.58B, resulting in a net margin of 5.7%.